Revo-i (robot surgeon)

2017: Approval on use

On August 3, 2017 the Korean Food and Drug Administration (KFDA, Korean Food and Drug Administration) approved to use of the first robot surgeon of South Korean production under the name Revo-i.

The robotic system developed by local company Meere Company Inc. is intended for carrying out endoscopic transactions, such as removal of a gall bladder and prostate gland.

Revo-i robot surgeon.

The Revo-i robot surgeon is equipped with four manipulators - "hands" which execute transaction through small cuts in a body of the person. Three of them hold surgical instruments, and one — the camera using which the doctor sees all events on an operational field. The image from the camera will be transformed to three-dimensional and output on the system display. The surgeon, using control block, can direct "hands" of the robot and do cuts, cut fabrics or impose seams on a wound.

Revo-i is the world's second robotic surgical system which got permission to carrying out real endoscopic transactions. The Da Vinci robot surgeon of production of the American company Intuitive Surgical was earlier only equipment of such class approved to use by supervisory authorities in the field of health care, declared in Management.^[1]

Also it is noted that the majority of other robotic systems applied today is executed by limited roles: for example, make recommendations in the course of transactions or are used during removal of a knee or coxofemoral joint in operations on their replacement with an artificial implant.

It is supposed that use of the robot surgeon of domestic development will allow to reduce a financial burden by persons in need in endoscopic transactions and will promote faster recovery of patients after surgical interventions, emphasized in KFDA.^[2]

Notes